In addition to inhibiting cyclooxygenase (COX)-1-derived prostanoid biosynthesis, aspirin acetylates COX-2, enabling the conversion of arachidonic acid to 15(R)-epi lipoxin A4, or aspirin-triggered ...

May 16, 2005 (Orlando) — Patients with stage III colon cancer may benefit from aspirin as much as from surgery and standard chemotherapy alone. A preliminary study found aspirin contributed to an ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Patients with stage III colon cancer who used aspirin ...

To the Editor: Chan et al. (May 24 issue) 1 evaluated the influence of aspirin on the risk of colorectal cancer according to the expression of cyclooxygenase-2 (COX-2) in the resected tumors and found ...

New insights into how colorectal cancers develop could lead to a targeted approach for using aspirin and other anti-inflammatory drugs to prevent the disease. While regular aspirin use has been shown ...

New research by scientists at the University of Pennsylvania School of Medicine has demonstrated that aspirin, ibuprofen and other drugs in the class of pharmaceuticals known as non-specific COX ...

Scientists have determined that the paradoxical prothrombotic effects of ultra-low-dose aspirin, that could have beneficial properties decreasing bleeding complications of portal hypertension, are ...

A long-term follow-up study that assessed the effect of daily aspirin on colorectal cancer incidence concluded that it significantly reduced the risk of colon cancer, but not rectal cancer. Detailed ...

Can taking aspirin or ibuprofen reduce your risk of getting breast cancer? One of the largest studies of its kind suggests that the answer might be yes. In the past, researchers have flip-flopped on ...

In 2006, the US Food and Drug Administration (FDA) alerted healthcare professionals about the potential for ibuprofen to interfere with the antiplatelet effect of low-dose aspirin (81 mg daily).